The Scientist : Venture Capital, with a Twist [18/7/2005]

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

For Advertisers

by Ted Agres

BIOBUSINESS

Venture Capital, with a Twist

Frustrated at the lack of treatments, disease advocacy groups seek to accelerate discoveries to the marketplace

Email: Ted Agres - tagres@the-scientist.com
The Scientist 2005, 19(14):45

Published

18 July 2005

Jamie Heywood, chief executive of the Amyotrophic Lateral Sclerosis Therapy Development Foundation (ALSTDF), founded the nonprofit biotech company in 1999 after his brother was diagnosed with ALS. To help identify potential therapies for the fatal neurological disorder, the foundation assembled a large mouse facility and ran some 250 drug screening, toxicology, and biomarker tests on about 10,000 SOD mice. They identified two drug candidates, both of which are in Phase I/II clinical trials cosponsored with another foundation.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today